Clinical trials in Pordenone

Groundbreaking research investigating the combined effects of baxdrostat and dapagliflozin in patients with chronic kidney disease and hypertension, aiming to reduce kidney failure risk and improve cardiovascular outcomes.

• Chronic Kidney Disease Management
• Hypertension Control
• Renal Function Preservation

Studies focus on preventing sustained decline in kidney function while managing blood pressure effectively.

Advanced clinical investigations of inclisiran in treating atherosclerotic cardiovascular disease, focusing on preventing heart attacks, strokes, and cardiovascular-related mortality.

• Cardiovascular Risk Reduction
• Stroke Prevention
• Heart Attack Prevention

Research targets improved outcomes for patients with established vascular disease through innovative therapeutic approaches.

Evaluation of atezolizumab as a monotherapy treatment for non-small cell lung cancer, comparing its efficacy against current standard care options for post-chemotherapy patients.

• Lung Cancer Treatment
• Disease-Free Survival
• Immunotherapy Advancement

Studies focus on improving survival rates and treatment outcomes in stage II-IIIA lung cancer patients.

Innovative study examining argon-based ventilation in cardiac arrest patients, investigating its potential to reduce neurological injury following successful resuscitation.

• Cardiac Arrest Management
• Neurological Protection
• Emergency Care Innovation

Research explores novel approaches to improve outcomes in cardiac arrest survivors through specialized ventilation techniques.